Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.

Lenacapavir will be available at low cost in 120 poor countries. But nearly all of Latin America was excluded from a deal ...

Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...

We still have 1.3 million new infections a year, the majority of which occur in marginalised and vulnerable groups. But we ...

A new HIV prevention drug, lenacapavir, has shown 100% effectiveness in women and near-perfect results in men during trials.

The twice-yearly HIV prevention shot developed by Gilead has shown impressive results in preventing infections among both men ...

It’s been called the closest the world has ever come to a vaccine against AIDS. The twice-yearly shot was 100% effective in ...

The drug has been called a profound advancement in medicine but getting it to those who need it is a "missing piece in the ...

Nov. 13, 2024 — An international team of scientists has identified a surprising factor that accelerates the degradation of lithium-ion batteries leading to a steady loss of charge. This ...

West Bengal CM Mamata Banerjee has urged the Centre to address the situation in Bangladesh by seeking UN intervention. She proposed deploying peacekeeping forces and offering shelter to persecuted ...